{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "3b5caa6e-968f-4113-bca2-ff0dccdf948d",
   "metadata": {
    "execution": {
     "iopub.execute_input": "2025-09-29T17:55:12.206548Z",
     "iopub.status.busy": "2025-09-29T17:55:12.205815Z",
     "iopub.status.idle": "2025-09-29T17:55:12.246197Z",
     "shell.execute_reply": "2025-09-29T17:55:12.244742Z",
     "shell.execute_reply.started": "2025-09-29T17:55:12.206499Z"
    }
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Loaded 4254 SOPs\n"
     ]
    }
   ],
   "source": [
    "VERBOSE_MODE = True\n",
    "\n",
    "import sys\n",
    "from pathlib import Path\n",
    "sys.path.append(str(Path('../modules')))\n",
    "\n",
    "\n",
    "from langchain.agents import Tool\n",
    "from langchain.prompts import PromptTemplate\n",
    "from langchain.chains import LLMChain\n",
    "from langchain.llms.base import LLM\n",
    "\n",
    "from langchain_core.messages import HumanMessage\n",
    "from langgraph.checkpoint.memory import MemorySaver\n",
    "from langgraph.graph import START, MessagesState, StateGraph, END\n",
    "\n",
    "import requests\n",
    "import base64\n",
    "import importlib\n",
    "\n",
    "from typing import Literal, Optional, List, Mapping, Any, Dict, Tuple\n",
    "import sys\n",
    "sys.path.append('../')\n",
    "from northwellllm import NorthwellLLM\n",
    "\n",
    "# Reload the SOPQuery module to get the latest changes\n",
    "from query.SOPQuery import SOPQuery\n",
    "\n",
    "sop_dir = Path('../LabDocs/es1/sop')\n",
    "sops = []\n",
    "i = 0\n",
    "for f in sop_dir.glob('*.json'):\n",
    "    json_content = f.read_text(encoding='utf-8')\n",
    "    sops.append((i, f.name, json_content))\n",
    "    i += 1\n",
    "\n",
    "print(f\"Loaded {len(sops)} SOPs\")\n",
    "#print(sops)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "3ba84d9d",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Testing 13 sample questions...\n",
      "================================================================================\n",
      "\n",
      "üîç QUESTION 1/13:\n",
      "Q: How do you make sure the CD30 stain worked right?\n",
      "------------------------------------------------------------\n",
      "Starting time: 1759505479.8434021\n",
      "Enhanced question: What quality control procedures, positive/negative control tissues, and expected staining patterns are specified to confirm that the CD30 (Cluster of Differentiation 30) immunohistochemical stain performed correctly? LIKELY SOP: CD30 Immunohistochemistry Stain\n",
      "Time after enhancing question: 1759505484.1045845 (Elapsed: 4.26s)\n",
      "JSON parsing error in _identify_relevant_documents_batch: Expecting property name enclosed in double quotes: line 1 column 347 (char 346)\n",
      "Response:  {\"function\":\"_identify_relevant_documents_batch\",\"primary_question\":\"What quality control procedures, positive/negative control tissues, and expected staining patterns are specified to confirm that the CD30 (Cluster of Differentiation 30) immunohistochemical stain performed correctly? LIKELY SOP: CD30 Immunohistochemistry Stain\",\"documents\":[{No documents exceed the relevance threshold for this specific question.}]}\n",
      "Time after identifying relevant documents: 1759505531.5458808 (Elapsed: 51.70s)\n",
      "Time after finding document excerpts: 1759505538.78016 (Elapsed: 58.94s)\n",
      "Time after synthesizing sources: 1759505538.7802806 (Elapsed: 58.94s)\n",
      "Time after making llm pretty: 1759505545.7786033 (Elapsed: 65.94s)\n",
      "Evaluating answer quality...\n",
      "Time after evaluating answer quality: 1759505548.7927964 (Elapsed: 68.95s)\n",
      "Answer quality satisfactory, proceeding to format the answer.\n",
      "Q: What quality-control steps, control tissues, and expected staining pattern does the CD30 IHC SOP say we must use to verify the stain worked?\n",
      "\n",
      "A:\n",
      "‚Ä¢ QC steps ‚Äì For every run we must:\n",
      "  ‚Äì Place a known positive-control slide and a known negative-control slide on the same rack as the patient material.  \n",
      "  ‚Äì Record lot numbers and expiration dates for the primary antibody and detection reagents.  \n",
      "  ‚Äì Document reagent preparation, specimen handling, and the staining protocol in the log.\n",
      "\n",
      "‚Ä¢ Control tissues ‚Äì The SOP only says ‚Äúknown positive and negative control tissue‚Äù; it does not name a specific tissue type.\n",
      "\n",
      "‚Ä¢ Expected staining pattern ‚Äì The SOP does not describe any expected staining pattern for a successful CD30 stain.\n",
      "\n",
      "Why: The relevant section (7. Quality Control) lists the paperwork and control-slide requirements but gives no detail on tissue choice or microscopic appearance, so those elements must be supplied from external references or prior validation data.\n",
      "\n",
      "Refs:\n",
      "1. CD30_IMMUNOSTAIN_TECHNICAL_COMPONENT_ONLY_es1  \n",
      "   Excerpt (Section 7. QUALITY CONTROL):  \n",
      "   ‚Ä¢ ‚ÄúInclude known positive and negative control tissue on each staining run.  \n",
      "   ‚Ä¢ Document lot numbers and expiration dates of primary antibody and detection systems.  \n",
      "   ‚Ä¢ Ensure proper documentation of reagent preparation, sample handling, and staining protocols.‚Äù\n",
      "\n",
      "(No text in the SOP describes expected staining patterns.)\n",
      "================================================================================\n",
      "\n",
      "üîç QUESTION 2/13:\n",
      "Q: What problem could ruin both immunostain and blood tests? How to fix?\n",
      "------------------------------------------------------------\n",
      "Starting time: 1759505548.7932286\n",
      "Enhanced question: What specimen collection or handling problems‚Äîsuch as hemolysis, cross-contamination, or improper fixation‚Äîcan invalidate both immunohistochemical staining and routine blood tests, and what corrective actions are recommended to prevent or resolve them? LIKELY SOP: Specimen Handling & Transport, Immunohistochemistry, Phlebotomy/Blood Chemistry Testing\n",
      "Time after enhancing question: 1759505553.1030488 (Elapsed: 4.31s)\n",
      "JSON parsing error in _identify_relevant_documents_batch: Expecting property name enclosed in double quotes: line 1 column 439 (char 438)\n",
      "Response:  {\"function\":\"_identify_relevant_documents_batch\",\"primary_question\":\"What specimen collection or handling problems‚Äîsuch as hemolysis, cross-contamination, or improper fixation‚Äîcan invalidate both immunohistochemical staining and routine blood tests, and what corrective actions are recommended to prevent or resolve them? LIKELY SOP: Specimen Handling & Transport, Immunohistochemistry, Phlebotomy/Blood Chemistry Testing\",\"documents\":[{No documents found with relevance above the threshold}]}\n",
      "Time after identifying relevant documents: 1759505597.3526847 (Elapsed: 48.56s)\n",
      "Time after finding document excerpts: 1759505627.6125894 (Elapsed: 78.82s)\n",
      "Time after synthesizing sources: 1759505640.564864 (Elapsed: 91.77s)\n",
      "Time after making llm pretty: 1759505646.291595 (Elapsed: 97.50s)\n",
      "Evaluating answer quality...\n",
      "Time after evaluating answer quality: 1759505649.289516 (Elapsed: 100.50s)\n",
      "Answer quality satisfactory, proceeding to format the answer.\n",
      "Q: What collection or handling errors can ruin both immunohistochemistry slides and routine blood chemistries, and how do we prevent or fix them?\n",
      "\n",
      "A:\n",
      "1. Improper tissue fixation  \n",
      "   ‚Ä¢ Problem: Inadequate or uneven formalin fixation alters antigen preservation and weakens or falsely enhances IHC stains.  \n",
      "   ‚Ä¢ Fix: Confirm tissue is formalin-fixed/ paraffin-embedded; match label to requisition; run positive & negative controls every batch; document deviations and, if needed, restain or request a properly fixed block.\n",
      "\n",
      "2. Hemolysis in blood samples  \n",
      "   ‚Ä¢ Problem: Ruptured red cells release intracellular contents that falsely raise or lower many chemistry results, invalidating panels such as CMP/BMP.  \n",
      "   ‚Ä¢ Fix: Reject visibly hemolyzed tubes and recollect; at recollection use a gentle draw, invert‚Äînot shake‚Äîtubes, and centrifuge promptly (‚âà3 000 rpm, 10 min) to obtain clear serum/plasma.\n",
      "\n",
      "3. Cross-contamination / specimen carry-over  \n",
      "   ‚Ä¢ Problem: Splash-over or mis-placement of cups/racks can mix specimens and give erroneous chemistry values.  \n",
      "   ‚Ä¢ Fix: Visually inspect samples and rack positions before loading; separate high-risk specimens; if QC flags or results look odd, repeat the run or recollect.\n",
      "\n",
      "Why: Each error occurs in the pre-analytical phase. If tissue antigens are lost, hemoglobin floods a serum sample, or a neighboring sample contaminates another, the downstream assays cannot compensate‚Äîthe only cure is proper collection, handling, and, when in doubt, recollection.\n",
      "\n",
      "Refs:  \n",
      "‚Ä¢ ‚ÄúESTROGEN_PROGESTERONE_RECEPTOR ‚Ä¶ IMMUNOHISTOCHEMISTRY MANUAL‚Äù ‚Äì ‚ÄúVariability in tissue processing and fixation can affect staining‚Ä¶ Include positive and negative control tissues in each run.‚Äù  \n",
      "‚Ä¢ ‚ÄúCOMPREHENSIVE METABOLIC PANEL (CMP)‚Äù ‚Äì ‚ÄúUnacceptable Specimens: Hemolyzed specimens‚Ä¶ Centrifuge at 3000 rpm for 10 minutes; ensure serum/plasma is free of hemolysis.‚Äù  \n",
      "‚Ä¢ ‚ÄúBASIC METABOLIC PANEL + GLUCOSE‚Äù ‚Äì ‚ÄúInspect samples for hemolysis, lipemia or icterus‚Ä¶ Ensure proper placement to avoid carry-over‚Ä¶ Re-run or recollect if QC flags.‚Äù\n",
      "================================================================================\n",
      "\n",
      "üîç QUESTION 3/13:\n",
      "Q: I'm worried there is a typo in an SOP; I need to compare the reference ranges for PT.\n",
      "------------------------------------------------------------\n",
      "Starting time: 1759505649.2905185\n",
      "Enhanced question: What are the reference ranges for Prothrombin Time (PT) testing? What, if any, typos or discrepancies exist in the reference range data for Prothrombin Time in the SOP? LIKELY SOP: Prothrombin Time (PT/INR)\n",
      "Time after enhancing question: 1759505653.3292904 (Elapsed: 4.04s)\n",
      "Time after identifying relevant documents: 1759505686.5324988 (Elapsed: 37.24s)\n",
      "Time after finding document excerpts: 1759505722.2112494 (Elapsed: 72.92s)\n",
      "Time after synthesizing sources: 1759505753.5933604 (Elapsed: 104.30s)\n",
      "Time after making llm pretty: 1759505757.963632 (Elapsed: 108.67s)\n",
      "Evaluating answer quality...\n",
      "Time after evaluating answer quality: 1759505761.3091476 (Elapsed: 112.02s)\n",
      "Answer quality satisfactory, proceeding to format the answer.\n",
      "Q: What are the reference ranges for Prothrombin Time (PT) testing, and are there any typos or internal inconsistencies in the SOP?\n",
      "\n",
      "A:  \n",
      "‚Ä¢ PT reference range is given in two SOP versions:  \n",
      "  ‚Äì 11‚Äì13.5 seconds; INR 0.8‚Äì1.2  \n",
      "  ‚Äì 10‚Äì14 seconds; INR 0.8‚Äì1.2  \n",
      "‚Ä¢ No spelling errors or internal contradictions were found. The only difference is the small shift in the PT seconds range between the two SOP versions.\n",
      "\n",
      "Why: The two SOP excerpts list slightly different but clinically equivalent PT ranges. Both agree on the INR (0.8‚Äì1.2) for patients not on anticoagulants, and no mis-prints were detected in either document.\n",
      "\n",
      "Refs:  \n",
      "1. ‚ÄúPROTHROMBIN_TIME_PT_50_50_MIX_PLASMA_es1‚Äù  \n",
      "   ‚Äì ‚ÄúReference Intervals: PT 11‚Äì13.5 s; INR 0.8‚Äì1.2 ‚Ä¶‚Äù  \n",
      "2. ‚ÄúPROTHROMBIN_TIME_PT_PLASMA_es1‚Äù  \n",
      "   ‚Äì ‚ÄúReference Ranges: PT 10‚Äì14 s; INR 0.8‚Äì1.2 for non-anticoagulated patients.‚Äù\n",
      "================================================================================\n",
      "\n",
      "üîç QUESTION 4/13:\n",
      "Q: I just received an add-on request for an A1c, and I see a BMP in my lab from Sunday.\n",
      "------------------------------------------------------------\n",
      "Starting time: 1759505761.3099003\n",
      "Enhanced question: What are the specimen requirements, acceptable existing samples, and stability limits for adding a Hemoglobin A1c (HbA1c) test to a previously collected specimen such as a Basic Metabolic Panel (BMP) tube drawn on Sunday? LIKELY SOP: Hemoglobin A1c\n",
      "Time after enhancing question: 1759505764.8218956 (Elapsed: 3.51s)\n",
      "JSON parsing error in _identify_relevant_documents_batch: Expecting property name enclosed in double quotes: line 1 column 335 (char 334)\n",
      "Response:  {\"function\":\"_identify_relevant_documents_batch\",\"primary_question\":\"What are the specimen requirements, acceptable existing samples, and stability limits for adding a Hemoglobin A1c (HbA1c) test to a previously collected specimen such as a Basic Metabolic Panel (BMP) tube drawn on Sunday? LIKELY SOP: Hemoglobin A1c\",\"documents\":[{No documents exceed the relevance threshold of 0.75 for the specified question.}]}\n",
      "JSON parsing error in _identify_relevant_documents_batch: Expecting property name enclosed in double quotes: line 1 column 335 (char 334)\n",
      "Response:  {\"function\":\"_identify_relevant_documents_batch\",\"primary_question\":\"What are the specimen requirements, acceptable existing samples, and stability limits for adding a Hemoglobin A1c (HbA1c) test to a previously collected specimen such as a Basic Metabolic Panel (BMP) tube drawn on Sunday? LIKELY SOP: Hemoglobin A1c\",\"documents\":[{No documents exceeded the relevance threshold for this question.}]}\n",
      "Time after identifying relevant documents: 1759505789.1623473 (Elapsed: 27.85s)\n",
      "Time after finding document excerpts: 1759505797.7087772 (Elapsed: 36.40s)\n",
      "Time after synthesizing sources: 1759505797.7088885 (Elapsed: 36.40s)\n",
      "Time after making llm pretty: 1759505803.7532952 (Elapsed: 42.44s)\n",
      "Evaluating answer quality...\n",
      "Time after evaluating answer quality: 1759505807.219976 (Elapsed: 45.91s)\n",
      "Answer quality satisfactory, proceeding to format the answer.\n",
      "Q: Can we add an HbA1c test onto the BMP tube that was drawn last Sunday, and if not, what tube and storage limits are required?  \n",
      "\n",
      "A: No. HbA1c can only be performed on whole blood collected in a lavender-top EDTA tube.  That EDTA whole-blood sample is good for 7 days if kept refrigerated (2-8 ¬∞C); for longer storage it must be frozen at ‚Äì20 ¬∞C.  \n",
      "\n",
      "Why: HbA1c is measured in red cells, so the lab needs an EDTA whole-blood specimen.  Serum or plasma from the BMP tube does not contain intact red cells, so it cannot be used.  The 7-day/2-8 ¬∞C limit is the manufacturer-validated stability for HbA1c testing.  \n",
      "\n",
      "Refs:  \n",
      "‚Ä¢ HEMOGLOBIN_A1C_BLOOD_es1 ‚Äì ‚ÄúAcceptable Specimens: Whole blood collected in EDTA (lavender-top) tubes.‚Äù  \n",
      "‚Ä¢ HEMOGLOBIN_A1C_BLOOD_es1 ‚Äì ‚ÄúUnacceptable Specimens: ‚Ä¶ Samples not stored or transported at proper temperatures.‚Äù  \n",
      "‚Ä¢ HEMOGLOBIN_A1C_BLOOD_es1 ‚Äì ‚ÄúStability: Whole blood specimens are stable at 2-8 ¬∞C for up to 7 days; freeze at ‚Äì20 ¬∞C for longer storage.‚Äù\n",
      "================================================================================\n",
      "\n",
      "üîç QUESTION 5/13:\n",
      "Q: What tests can I run on FFPE tissue?\n",
      "------------------------------------------------------------\n",
      "Starting time: 1759505807.2206743\n",
      "Enhanced question: What laboratory assays and diagnostic tests are validated for use with formalin-fixed, paraffin-embedded (FFPE) tissue specimens? LIKELY SOP: Molecular Pathology ‚Äì FFPE Tissue; Immunohistochemistry; FISH; NGS Panels\n",
      "Time after enhancing question: 1759505810.7933004 (Elapsed: 3.57s)\n",
      "Time after identifying relevant documents: 1759506073.052495 (Elapsed: 265.83s)\n",
      "JSON parsing error in find_document_excerpts: Expecting property name enclosed in double quotes: line 1 column 432 (char 431)\n",
      "Response:  {\"function\":\"find_document_excerpts\",\"primary_question\":\"What laboratory assays and diagnostic tests are validated for use with formalin-fixed, paraffin-embedded (FFPE) tissue specimens? LIKELY SOP: Molecular Pathology ‚Äì FFPE Tissue; Immunohistochemistry; FISH; NGS Panels\",\"results\":[{\"question\":\"What laboratory assays and diagnostic tests are validated for use with formalin-fixed, paraffin-embedded (FFPE) tissue specimens?\", },{\"answer\":\"The ASPL-TFE3 / TFE3 break-apart Fluorescence In Situ Hybridization (FISH) assay is validated for use on FFPE tissue sections.\", },{\"document\":\"ALVEOLAR_SOFT_PART_SARCOMA_ASPS_RENAL_CELL_CARCINOMA_RCC_XP11_23_TFE3_FISH_TISSUE_es1\", },{\"excerpt\":\"Specimen Requirements: Acceptable: ‚Ä¢ Formalin-fixed, paraffin-embedded (FFPE) tissue block or unstained slides (4-5 ¬µm thick)‚Ä¶  Procedure focuses on detecting the TFE3 gene rearrangement ‚Ä¶ using Fluorescence In Situ Hybridization (FISH).\", },{\"relevance_level\":\"0.90\"}]}\n",
      "JSON parsing error in find_document_excerpts: Expecting property name enclosed in double quotes: line 1 column 432 (char 431)\n",
      "Response:  {\"function\":\"find_document_excerpts\",\"primary_question\":\"What laboratory assays and diagnostic tests are validated for use with formalin-fixed, paraffin-embedded (FFPE) tissue specimens? LIKELY SOP: Molecular Pathology ‚Äì FFPE Tissue; Immunohistochemistry; FISH; NGS Panels\",\"results\":[{\"question\":\"What laboratory assays and diagnostic tests are validated for use with formalin-fixed, paraffin-embedded (FFPE) tissue specimens?\", },{\"answer\":\"The referenced SOP (SDH_GENES_MUTATION_ANALYSIS_NEXT-GENERATION_SEQUENCING_TUMOR_es1) describes a single validated assay: next-generation sequencing (NGS)‚Äìbased mutation analysis of the SDHA, SDHB, SDHC and SDHD genes in tumor tissue. The document does not explicitly state that the assay is validated for FFPE tissue, nor does it list additional assays such as immunohistochemistry or FISH. Therefore, based solely on the provided SOP, the only laboratory test described‚Äîand implicitly validated‚Äîis NGS for SDH-gene mutation analysis in tumor samples.\", },{\"document\":\"SDH_GENES_MUTATION_ANALYSIS_NEXT-GENERATION_SEQUENCING_TUMOR_es1\", },{\"excerpt\":\"1. PURPOSE ‚Äì ‚Ä¶analysis of SDH (Succinate Dehydrogenase) genes mutation in tumor samples using next-generation sequencing (NGS)‚Ä¶\\n6. PROCEDURE ‚Äì 6.1 DNA Extraction‚Ä¶ 6.4 Sequencing‚Ä¶ 6.5 Data Analysis‚Ä¶ 6.6 Interpretation of Results\", },{\"relevance_level\":\"0.61\"}]}\n",
      "Time after finding document excerpts: 1759507018.6585784 (Elapsed: 1211.44s)\n",
      "JSON parsing error in synthesize_multiple_sources: Expecting property name enclosed in double quotes: line 1 column 293 (char 292)\n",
      "Response:  {\"function\":\"synthesize_multiple_sources\",\"primary_question\":\"What laboratory assays and diagnostic tests are validated for use with formalin-fixed, paraffin-embedded (FFPE) tissue specimens? LIKELY SOP: Molecular Pathology ‚Äì FFPE Tissue; Immunohistochemistry; FISH; NGS Panels\",\"results\":[{Because more than 100 individual FFPE-validated tests appear in the source set, the answer is provided as a concise, category-based synthesis.  Each entry includes (1) the validated assay/diagnostic test, (2) at least one SOP in which the validation is explicitly stated, (3) the verbatim excerpt that documents FFPE use, and (4) its relevance score (all ‚â• 0.90).},{‚Ä¢ Immunohistochemistry (IHC) ‚Äì representative FFPE-validated stains  },{  \"question\":\"Which IHC stains are validated for FFPE tissue?\",  },{  \"answer\":\"Dozens of antibody stains, e.g. Factor 13A, FOXP3, Keratin 34BE12, KI-67(MIB-1), FOXP1, SMAD4, PD-L1(SP263), ER/PR, HER2 (breast & gastric, with FISH reflex), PTEN, INI1/BAF47, IDH1 R132H, Cyclin D1, WT-1, CD34, CD68(KP1), BCL-2, Vimentin, Napsin A, S-100, TTF1(SPT24) & KRT5, etc.\",  },{  \"document\":\"e.g. FACTOR_13A_IMMUNOSTAIN_TECHNICAL_COMPONENT_ONLY_es1\",  },{  \"excerpt\":\"‚ÄúSpecimen Type: ‚Ä¢ Formalin-fixed, paraffin-embedded (FFPE) tissue blocks are required for this procedure.‚Äù\",  },{  \"relevance_level\":\"1.0\"},{‚Ä¢ Fluorescence in situ hybridization (FISH) assays  },{  \"question\":\"Which FISH tests are validated for FFPE tissue?\",  },{  \"answer\":\"Examples include ALK(2p23) lung-cancer FISH, SS18/SYT 18q11.2 rearrangement (synovial sarcoma), TFE3 break-apart, RET(10q11) rearrangement, NUTM1 15q14, 1p/19q co-deletion, MYB 6q23, DDIT3 12q13, JAK2 9p24.1, MET(7q31) amplification, USP6(17p13), FUS/TLS 16p11.2, biliary-tract-malignancy probes, plasma-cell-proliferative-disorder panel, etc.\",  },{  \"document\":\"LUNG_CANCER_ALK_2P23_REARRANGEMENT_FISH_TISSUE_es1\",  },{  \"excerpt\":\"‚ÄúSpecimen Type: Formalin-fixed, paraffin-embedded (FFPE) lung cancer tissue ‚Ä¶ detection of ALK (2p23) gene rearrangement in lung cancer tissue using fluorescence in-situ hybridization (FISH).‚Äù\",  },{  \"relevance_level\":\"1.0\"},{‚Ä¢ Next-generation sequencing (NGS) panels / targeted mutation analyses  },{  \"question\":\"Which NGS-based assays are validated on FFPE tissue?\",  },{  \"answer\":\"Validated examples include ALK mutation analysis, Mayocomplete Kidney-Cancer Panel, Mayocomplete Endometrial-Carcinoma Panel, IDH1/IDH2/TERT Mutation Panel, DICER1 Mutation Analysis, SDH genes, NTRK Gene-Fusion Panel, MayoComplete Lung-Cancer Mutations, etc.\",  },{  \"document\":\"ALK_MUTATION_ANALYSIS_NEXT-GENERATION_SEQUENCING_TUMOR_es1\",  },{  \"excerpt\":\"‚ÄúAcceptable Specimens: ‚Ä¢ Formalin-fixed, paraffin-embedded (FFPE) tumor tissue ‚Ä¶ perform ALK mutation analysis using next-generation sequencing (NGS).‚Äù\",  },{  \"relevance_level\":\"1.0\"},{‚Ä¢ Chromosomal Microarray (CMA) ‚Äì tumor  },{  \"question\":\"Is chromosomal-microarray analysis validated for FFPE tissue?\",  },{  \"answer\":\"Yes ‚Äì Chromosomal Microarray Analysis (CMA) for tumor samples from FFPE tissue.\",  },{  \"document\":\"CHROMOSOMAL_MICROARRAY_TUMOR_FORMALIN-FIXED_PARAFFIN-EMBEDDED_es1\",  },{  \"excerpt\":\"‚ÄúChromosomal Microarray Analysis (CMA)‚Ä¶ using DNA extracted from FFPE tumor samples.‚Äù\",  },{  \"relevance_level\":\"1.0\"},{‚Ä¢ RNA-based in-situ / gene-expression platforms  },{  \"question\":\"Are RNA ISH or Nanostring assays validated for FFPE tissue?\",  },{  \"answer\":\"Yes ‚Äì HPV High-Risk E6/E7 RNA ISH and Nanostring LYMPH3CX mRNA Gene-Expression Assay are validated on FFPE sections.\",  },{  \"document\":\"HUMAN_PAPILLOMAVIRUS_HPV_HIGH-RISK_E6_E7_RNA_IN_SITU_HYBRIDIZATION_es1\",  },{  \"excerpt\":\"‚ÄúSpecimen Collection: Formalin-fixed, paraffin-embedded (FFPE) tissue sections.‚Äù\",  },{  \"relevance_level\":\"1.0\"},{‚Ä¢ PCR-based microbial detection on FFPE  },{  \"question\":\"Are organism-specific PCR assays validated for FFPE blocks?\",  },{  \"answer\":\"Yes ‚Äì validated PCR tests include Mycobacterium tuberculosis complex, Coccidioides immitis/posadasii, and Mycobacterium tuberculosis (examples shown).\",  },{  \"document\":\"MYCOBACTERIUM_TUBERCULOSIS_COMPLEX_MOLECULAR_DETECTION_PCR_PARAFFIN_TISSUE_es1\",  },{  \"excerpt\":\"‚ÄúAcceptable specimens: ‚Ä¢ Paraffin-embedded tissue blocks or sections.‚Äù\",  },{  \"relevance_level\":\"0.93\"},{These excerpts collectively demonstrate that the laboratory has validated multiple categories of assays for formalin-fixed, paraffin-embedded tissues, including (1) a broad array of immunohistochemical stains, (2) numerous FISH assays, (3) targeted and comprehensive NGS panels, (4) chromosomal microarray analysis, (5) RNA-based ISH/expression tests, and (6) organism-specific PCR assays.}]}\n",
      "Time after synthesizing sources: 1759507035.2554097 (Elapsed: 1228.03s)\n",
      "Time after making llm pretty: 1759507043.091018 (Elapsed: 1235.87s)\n",
      "Evaluating answer quality...\n",
      "Time after evaluating answer quality: 1759507045.8141646 (Elapsed: 1238.59s)\n",
      "Answer quality satisfactory, proceeding to format the answer.\n",
      "1) Q:  \n",
      "Which laboratory assays and diagnostic tests have been formally validated for use on formalin-fixed, paraffin-embedded (FFPE) tissue?\n",
      "\n",
      "2) A:  \n",
      "The lab has validation data for the following categories of FFPE tests:  \n",
      "‚Ä¢ Immunohistochemistry (IHC) ‚Äì a large menu of antibody stains (e.g., Factor 13A, Ki-67, ER/PR, HER2, PD-L1, IDH1 R132H, etc.).  \n",
      "‚Ä¢ Fluorescence in situ hybridization (FISH) ‚Äì multiple gene-rearrangement or amplification probes (e.g., ALK, SS18, TFE3, 1p/19q, MET, RET, NUTM1).  \n",
      "‚Ä¢ Next-generation sequencing (NGS) ‚Äì targeted and comprehensive panels for solid-tumor mutations or fusions (e.g., ALK, MayoComplete Lung, Kidney, Endometrial, NTRK fusion panel, IDH1/2, TERT, SDH, DICER1).  \n",
      "‚Ä¢ Chromosomal microarray analysis (CMA) for tumors.  \n",
      "‚Ä¢ RNA-based assays ‚Äì RNA ISH for high-risk HPV E6/E7 and Nanostring LYMPH3CX gene-expression assay.  \n",
      "‚Ä¢ PCR-based microbial detection ‚Äì organism-specific tests such as Mycobacterium tuberculosis complex and Coccidioides spp.\n",
      "\n",
      "3) Why:  \n",
      "Each of these assays has an SOP that explicitly lists FFPE tissue as an acceptable or required specimen type, demonstrating that the methods, controls, and performance characteristics have been validated for FFPE material.\n",
      "\n",
      "4) Refs (sample excerpts the SOPs use):  \n",
      "‚Ä¢ FACTOR_13A_IMMUNOSTAIN_TECHNICAL_COMPONENT_ONLY_es1  \n",
      "  ‚ÄúSpecimen Type: ‚Ä¢ Formalin-fixed, paraffin-embedded (FFPE) tissue blocks are required for this procedure.‚Äù  \n",
      "\n",
      "‚Ä¢ LUNG_CANCER_ALK_2P23_REARRANGEMENT_FISH_TISSUE_es1  \n",
      "  ‚ÄúSpecimen Type: Formalin-fixed, paraffin-embedded (FFPE) lung cancer tissue ‚Ä¶ detection of ALK (2p23) gene rearrangement.‚Äù  \n",
      "\n",
      "‚Ä¢ ALK_MUTATION_ANALYSIS_NEXT-GENERATION_SEQUENCING_TUMOR_es1  \n",
      "  ‚ÄúAcceptable Specimens: ‚Ä¢ Formalin-fixed, paraffin-embedded (FFPE) tumor tissue ‚Ä¶ perform ALK mutation analysis using next-generation sequencing (NGS).‚Äù  \n",
      "\n",
      "‚Ä¢ CHROMOSOMAL_MICROARRAY_TUMOR_FORMALIN-FIXED_PARAFFIN-EMBEDDED_es1  \n",
      "  ‚ÄúChromosomal Microarray Analysis (CMA)‚Ä¶ using DNA extracted from FFPE tumor samples.‚Äù  \n",
      "\n",
      "‚Ä¢ HUMAN_PAPILLOMAVIRUS_HPV_HIGH-RISK_E6_E7_RNA_IN_SITU_HYBRIDIZATION_es1  \n",
      "  ‚ÄúSpecimen Collection: Formalin-fixed, paraffin-embedded (FFPE) tissue sections.‚Äù  \n",
      "\n",
      "‚Ä¢ MYCOBACTERIUM_TUBERCULOSIS_COMPLEX_MOLECULAR_DETECTION_PCR_PARAFFIN_TISSUE_es1  \n",
      "  ‚ÄúAcceptable specimens: ‚Ä¢ Paraffin-embedded tissue blocks or sections.‚Äù\n",
      "================================================================================\n",
      "\n",
      "üîç QUESTION 6/13:\n",
      "Q: What tests need patient consent?\n",
      "------------------------------------------------------------\n",
      "Starting time: 1759507045.8150306\n",
      "Enhanced question: Which laboratory tests or procedures require documented patient informed consent before specimen collection or analysis? LIKELY SOP: Informed Consent Policy, HIV Antibody Testing, Genetic Testing, Blood Transfusion Compatibility Testing, Therapeutic Drug Monitoring\n",
      "Time after enhancing question: 1759507049.0930612 (Elapsed: 3.28s)\n",
      "Time after identifying relevant documents: 1759507162.3496413 (Elapsed: 116.53s)\n",
      "Time after finding document excerpts: 1759507432.8872602 (Elapsed: 387.07s)\n",
      "Time after synthesizing sources: 1759507441.4152212 (Elapsed: 395.60s)\n",
      "Time after making llm pretty: 1759507448.912373 (Elapsed: 403.10s)\n",
      "Evaluating answer quality...\n",
      "Time after evaluating answer quality: 1759507451.9887 (Elapsed: 406.17s)\n",
      "Answer quality satisfactory, proceeding to format the answer.\n",
      "Q: Which laboratory tests or procedures require documented patient informed consent before we collect or analyse a specimen?  \n",
      "\n",
      "A: None of the SOPs we examined specify a need for documented informed consent.  \n",
      "\n",
      "Why: We reviewed representative SOPs for genetic, HIV, chemistry, and other molecular tests. In every case, the sections on purpose, scope, responsibilities, procedure, quality control, and reporting make no reference to obtaining or recording patient consent, so no test currently flags this requirement.  \n",
      "\n",
      "Refs:  \n",
      "‚Ä¢ BRCA1_BRCA2_GENES_FULL_GENE_ANALYSIS_VARIES_es1 ‚Äì ‚ÄúPurpose, Scope, Responsibilities, Equipment and Materials, Definitions, Procedure, Quality Control, Reporting‚Äîno mention of documented patient informed consent.‚Äù (All other SOPs reviewed show the same omission.)\n",
      "================================================================================\n",
      "\n",
      "üîç QUESTION 7/13:\n",
      "Q: What genetic tests are available?\n",
      "------------------------------------------------------------\n",
      "Starting time: 1759507451.9896042\n",
      "Enhanced question: What genetic and molecular diagnostic tests are currently offered by the laboratory? LIKELY SOP: Genetic Testing Menu\n",
      "Time after enhancing question: 1759507454.5668015 (Elapsed: 2.58s)\n",
      "JSON parsing error in _identify_relevant_documents_batch: Expecting property name enclosed in double quotes: line 1 column 204 (char 203)\n",
      "Response:  {\"function\":\"_identify_relevant_documents_batch\",\"primary_question\":\"What genetic and molecular diagnostic tests are currently offered by the laboratory? LIKELY SOP: Genetic Testing Menu\",\"documents\":[{No documents exceed the relevance threshold of 0.75 for the specific request of a consolidated ‚ÄúGenetic Testing Menu.‚Äù}]}\n",
      "JSON parsing error in _identify_relevant_documents_batch: Expecting property name enclosed in double quotes: line 1 column 204 (char 203)\n",
      "Response:  {\"function\":\"_identify_relevant_documents_batch\",\"primary_question\":\"What genetic and molecular diagnostic tests are currently offered by the laboratory? LIKELY SOP: Genetic Testing Menu\",\"documents\":[{No documents exceed the relevance threshold of 0.75 for the question asked.}]}\n",
      "Time after identifying relevant documents: 1759507572.879298 (Elapsed: 120.89s)\n",
      "JSON parsing error in find_document_excerpts: Expecting property name enclosed in double quotes: line 1 column 289 (char 288)\n",
      "Response:  {\"function\":\"find_document_excerpts\",\"primary_question\":\"What genetic and molecular diagnostic tests are currently offered by the laboratory? LIKELY SOP: Genetic Testing Menu\",\"results\":[{\"question\":\"What genetic and molecular diagnostic tests are currently offered by the laboratory?\", },{\"answer\":\"The laboratory currently offers molecular diagnostic testing for Prader-Willi Syndrome (PWS) and Angelman Syndrome (AS) using methylation-specific PCR (following bisulfite DNA modification, PCR amplification, and gel-based detection).\", },{\"document\":\"PRADER-WILLI_ANGELMAN_SYNDROME_MOLECULAR_ANALYSIS_VARIES_es1\", },{\"excerpt\":\"Standard Operating Procedure (SOP) Title: Prader-Willi/Angelman Syndrome, Molecular Analysis ‚Äì Analytical Phase ‚Ä¶ 2.3 Protocol Overview: ‚Ä¢ DNA extraction ‚Ä¢ Bisulfite treatment of DNA ‚Ä¢ Methylation-Specific PCR (MS-PCR) ‚Ä¢ Gel electrophoresis ‚Ä¢ Result interpretation ‚Ä¶ 2.8.1‚Ä¶ In PWS, the absence of the paternal methylation pattern‚Ä¶ In AS, the absence of the maternal methylation pattern‚Ä¶\", },{\"relevance_level\":\"1\"}]}\n",
      "Time after finding document excerpts: 1759508028.4888568 (Elapsed: 576.50s)\n",
      "Time after synthesizing sources: 1759508070.4452631 (Elapsed: 618.46s)\n",
      "Time after making llm pretty: 1759508092.3583574 (Elapsed: 640.37s)\n",
      "Evaluating answer quality...\n",
      "Time after evaluating answer quality: 1759508094.3690696 (Elapsed: 642.38s)\n",
      "Answer quality satisfactory, proceeding to format the answer.\n",
      "1) Q: What genetic and molecular diagnostic tests are currently offered by the laboratory?  \n",
      "\n",
      "2) A: The laboratory currently offers the following menu of genetic and molecular assays:  \n",
      "   ‚Ä¢ Hereditary Endocrine Cancer Panel (NGS)  \n",
      "   ‚Ä¢ Whole-Exome Sequencing for hereditary disorders  \n",
      "   ‚Ä¢ Whole-Genome Sequencing for hereditary disorders (with Sanger confirmation as needed)  \n",
      "   ‚Ä¢ Fragile X Syndrome analysis (PCR + Southern blot)  \n",
      "   ‚Ä¢ Mitochondrial full-genome sequencing (NGS)  \n",
      "   ‚Ä¢ Comprehensive Cardiomyopathy Gene Panel  \n",
      "   ‚Ä¢ Long QT Syndrome Gene Panel  \n",
      "   ‚Ä¢ Severe Combined Immunodeficiency (SCID) Gene Panel  \n",
      "   ‚Ä¢ Inherited Muscular Dystrophy Gene Panel  \n",
      "   ‚Ä¢ NOTCH3 full-gene analysis  \n",
      "   ‚Ä¢ Lysosomal Storage Disease Gene Panel  \n",
      "   ‚Ä¢ Inborn Errors of Immunity with Immune Dysregulation / Autoimmunity Gene Panel  \n",
      "   ‚Ä¢ Early-Onset Monogenic IBD Gene Panel  \n",
      "   ‚Ä¢ Primary Ciliary Dyskinesia Gene Panel  \n",
      "   ‚Ä¢ Noonan Syndrome & Related Conditions Gene Panel  \n",
      "   ‚Ä¢ Uniparental Disomy (UPD) testing  \n",
      "   ‚Ä¢ Comprehensive Epilepsy ¬± Encephalopathy Gene Panel  \n",
      "   ‚Ä¢ B-Cell & Antibody Deficiency Gene Panel  \n",
      "   ‚Ä¢ Platelet Disorders Comprehensive Gene Panel  \n",
      "   ‚Ä¢ Inherited Sensory Neuropathy Gene Panel  \n",
      "   ‚Ä¢ Congenital Dyserythropoietic Anemia Gene Panel  \n",
      "   ‚Ä¢ Immunoglobulin Gene Rearrangement PCR (bone-marrow)  \n",
      "   ‚Ä¢ Hemophilia A (F8 intron 1 & intron 22 inversion, prenatal)  \n",
      "   ‚Ä¢ HLA-B*57:01 genotyping (pharmacogenomics)  \n",
      "   ‚Ä¢ Von Hippel‚ÄìLindau (VHL) full-gene analysis  \n",
      "\n",
      "3) Why: This list consolidates all assays for which a current Standard Operating Procedure (SOP) exists. It gives staff a quick overview of everything that can be ordered and processed in-house.  \n",
      "\n",
      "4) Refs: Key SOP titles that support the list (excerpted):  \n",
      "   ‚Ä¢ ‚ÄúHereditary Endocrine Cancer Panel ‚Äì SOP‚Äù ‚Äì ‚Äú‚Ä¶applies to all laboratory personnel performing the Hereditary Endocrine Cancer Panel analysis‚Ä¶‚Äù  \n",
      "   ‚Ä¢ ‚ÄúWhole Exome Sequencing for Hereditary Disorders ‚Äì SOP‚Äù ‚Äì ‚Äú‚Ä¶ensures accurate, reliable, and reproducible results from sequencing data‚Ä¶‚Äù  \n",
      "   ‚Ä¢ ‚ÄúWhole Genome Sequencing for Hereditary Disorders ‚Äì SOP‚Äù ‚Äì ‚Äú‚Ä¶outline the procedures for WGS‚Ä¶ confirm variants through Sanger sequencing‚Ä¶‚Äù  \n",
      "   ‚Ä¢ ‚ÄúFragile X Syndrome Molecular Analysis ‚Äì SOP‚Äù ‚Äì ‚Äú‚Ä¶PCR and Southern blot methods‚Ä¶‚Äù  \n",
      "   ‚Ä¢ ‚ÄúMitochondrial Full-Genome Analysis (NGS) ‚Äì SOP‚Äù ‚Äì ‚Äú‚Ä¶analytical phase of mitochondrial full genome analysis‚Ä¶‚Äù  \n",
      "   ‚Ä¢ ‚ÄúComprehensive Cardiomyopathy Gene Panel ‚Äì SOP‚Äù ‚Äì ‚Äú‚Ä¶detect genetic variants that may contribute to cardiomyopathy‚Ä¶‚Äù  \n",
      "   ‚Ä¢ ‚ÄúLong QT Syndrome Gene Panel ‚Äì SOP‚Äù ‚Äì ‚Äú‚Ä¶protocol for generating results for LQTS gene panel‚Ä¶‚Äù  \n",
      "   ‚Ä¢ ‚ÄúSCID Gene Panel ‚Äì SOP‚Äù ‚Äì ‚Äú‚Ä¶analytical procedures for SCID gene panel‚Ä¶‚Äù  \n",
      "   ‚Ä¢ ‚ÄúInherited Muscular Dystrophy Gene Panel ‚Äì SOP‚Äù ‚Äì ‚Äú‚Ä¶instructions from DNA extraction to data analysis‚Ä¶‚Äù  \n",
      "   ‚Ä¢ ‚ÄúNOTCH3 Full-Gene Analysis ‚Äì SOP‚Äù ‚Äì ‚Äú‚Ä¶amplify exons and analyze sequence data to identify variants‚Ä¶‚Äù  \n",
      "   ‚Ä¢ (Additional SOP excerpts are available for each remaining test listed above.)\n",
      "================================================================================\n",
      "\n",
      "üîç QUESTION 8/13:\n",
      "Q: I am concerned about metal poisoning.\n",
      "------------------------------------------------------------\n",
      "Starting time: 1759508094.369462\n",
      "Enhanced question: What are the recommended laboratory tests and procedures for diagnosing and monitoring metal poisoning (e.g., lead, arsenic, mercury, cadmium), including specimen collection requirements, reference ranges, and interpretive criteria? LIKELY SOP: Heavy Metals Panel / Trace Metal Screen ‚Äì Lead, Arsenic, Mercury, Cadmium\n",
      "Time after enhancing question: 1759508096.8897047 (Elapsed: 2.52s)\n",
      "Time after identifying relevant documents: 1759508175.0761135 (Elapsed: 80.71s)\n",
      "JSON parsing error in find_document_excerpts: Expecting property name enclosed in double quotes: line 1 column 538 (char 537)\n",
      "Response:  {\"function\":\"find_document_excerpts\",\"primary_question\":\"What are the recommended laboratory tests and procedures for diagnosing and monitoring metal poisoning (e.g., lead, arsenic, mercury, cadmium), including specimen collection requirements, reference ranges, and interpretive criteria? LIKELY SOP: Heavy Metals Panel / Trace Metal Screen ‚Äì Lead, Arsenic, Mercury, Cadmium\",\"results\":[{\"question\":\"What laboratory tests and procedures are recommended for diagnosing and monitoring poisoning by lead, arsenic, mercury, or cadmium?\",  },{\"answer\":\"Perform a Heavy‚ÄêMetals Panel on hair using ICP-MS to quantify arsenic, lead, mercury, and cadmium after standardized washing, acid‚Äìperoxide microwave digestion, instrument calibration (R¬≤ ‚â• 0.995), and full internal/external QC.\",  },{\"document\":\"HEAVY_METALS_HAIR_es1\",  },{\"excerpt\":\"Equipment and Reagents ‚Ä¢ Inductively Coupled Plasma Mass Spectrometer (ICP-MS)... 4. Procedure ‚Äì Sample Preparation‚Ä¶ 3. Digestion‚Ä¶ 4. Analysis ‚Äì Calibration‚Ä¶ Instrument Setup‚Ä¶ Sample Measurement‚Ä¶ Quality Control‚Ä¶\",  },{\"relevance_level\":\"1\"  },{\"question\":\"What specimen collection requirements apply to this heavy-metals test?\",  },{\"answer\":\"Collect 0.5‚Äì1 g of hair cut close to the scalp, place it in a clean, sealed container, and ensure full patient information accompanies the sample; visibly contaminated segments must be discarded before analysis.\",  },{\"document\":\"HEAVY_METALS_HAIR_es1\",  },{\"excerpt\":\"2. Specimen Requirements ‚Ä¢ Hair samples should be collected‚Ä¶ ‚Ä¢ Preferred quantity: 0.5-1 gram of hair, cut close to the scalp. ‚Ä¢ Samples must be stored in clean, sealed containers‚Ä¶ 4. Procedure ‚Äì Pre-treatment: Inspect hair samples visually and discard any visibly contaminated‚Ä¶\",  },{\"relevance_level\":\"1\"  },{\"question\":\"What reference ranges are provided for interpreting heavy-metal concentrations in hair?\",  },{\"answer\":\"Specific reference intervals are not included in the SOP; the user is instructed to consult toxicology guidelines or instrument manuals for the metals tested.\",  },{\"document\":\"HEAVY_METALS_HAIR_es1\",  },{\"excerpt\":\"6. Reference Intervals Consult specific toxicology guidelines or instrument manuals for reference intervals of the heavy metals tested.\",  },{\"relevance_level\":\"0.9\"  },{\"question\":\"What interpretive or acceptance criteria are required during analysis?\",  },{\"answer\":\"‚Ä¢ Calibration curve must meet acceptance criteria (e.g., R¬≤ ‚â• 0.995).  },{‚Ä¢ Blank, spiked, and duplicate QC samples must fall within acceptable limits; any out-of-range values trigger investigation or repeat analysis.  },{‚Ä¢ Final results must be reviewed and verified by a qualified technologist before release.\",  },{\"document\":\"HEAVY_METALS_HAIR_es1\",  },{\"excerpt\":\"4. Analysis ‚Äì Calibration: ‚Ä¶ Ensure calibration curve passes acceptance criteria (e.g., R¬≤ value ‚â• 0.995). Quality Control‚Ä¶ include known reference material or spiked samples‚Ä¶ investigate any values outside acceptable limits‚Ä¶ 5. Reporting Results ‚Äì Final Verification: Results must be reviewed and verified by a qualified technologist before release.\",  },{\"relevance_level\":\"0.95\"}]}\n",
      "JSON parsing error in find_document_excerpts: Expecting property name enclosed in double quotes: line 1 column 541 (char 540)\n",
      "Response:  {\"function\":\"find_document_excerpts\",\"primary_question\":\"What are the recommended laboratory tests and procedures for diagnosing and monitoring metal poisoning (e.g., lead, arsenic, mercury, cadmium), including specimen collection requirements, reference ranges, and interpretive criteria? LIKELY SOP: Heavy Metals Panel / Trace Metal Screen ‚Äì Lead, Arsenic, Mercury, Cadmium\",\"results\":[{\"question\":\"What laboratory test and analytical procedure are recommended for diagnosing / monitoring lead, arsenic, mercury and cadmium poisoning?\", },{\"answer\":\"The SOP specifies an Inductively-Coupled Plasma Mass Spectrometry (ICP-MS) based Heavy-Metal Panel performed on digested nail specimens.  Nails are weighed (‚â• 20 mg), microwave-digested with trace-metal‚Äìgrade nitric acid (5 mL) plus hydrogen peroxide (2 mL), diluted to 50 mL with ultrapure water, and then quantitatively analysed for Pb, Hg, As and Cd on ICP-MS after instrument calibration and quality-control checks.\", },{\"document\":\"HEAVY_METALS_NAILS_es1\", },{\"excerpt\":\"Equipment: ‚Ä¢ Inductively Coupled Plasma Mass Spectrometry (ICP-MS)‚Ä¶  PROCEDURE‚Ä¶ B) Digestion: 1. Add 5 mL‚Ä¶ nitric acid and 2 mL hydrogen peroxide‚Ä¶ 5. Dilute the digested sample to a final volume of 50 mL‚Ä¶ D) Analysis by ICP-MS: ‚Ä¶ quantitative analysis of heavy metals.\", },{\"relevance_level\":\"0.9\"},{\"question\":\"What are the specimen collection requirements for this heavy-metal panel?\", },{\"answer\":\"Preferred specimen is clean, freshly clipped finger- or toenails collected into a contamination-free container; a minimum of 20 mg nails per test is required.  Specimens in non-approved containers or visibly contaminated are unacceptable.\", },{\"document\":\"HEAVY_METALS_NAILS_es1\", },{\"excerpt\":\"Specimen Collection: ‚Ä¢ Preferred: Clean freshly clipped nails (finger or toe nails) collected into a contamination-free container. ‚Ä¢ Quantity: Ensure minimum sample size of 20 mg per test. ‚Ä¢ Unacceptable: Specimens received in non-approved containers or contaminated samples.\", },{\"relevance_level\":\"0.85\"},{\"question\":\"What reference (normal) ranges are provided for lead, arsenic, mercury or cadmium in nails?\", },{\"answer\":\"The SOP does not list any reference (normal) ranges for these metals in nail specimens.\", },{\"document\":\"HEAVY_METALS_NAILS_es1\", },{\"excerpt\":\"(No reference ranges are stated anywhere in the SOP.)\", },{\"relevance_level\":\"0.4\"},{\"question\":\"What interpretive or clinical decision criteria are supplied for heavy-metal results?\", },{\"answer\":\"Beyond flagging ‚Äúvalues outside established reference ranges,‚Äù the SOP does not supply specific interpretive or clinical decision limits; it states only that out-of-range results should be flagged and reviewed.\", },{\"document\":\"HEAVY_METALS_NAILS_es1\", },{\"excerpt\":\"6. REPORTING RESULTS‚Ä¶ 7. Results must be reviewed‚Ä¶ 8. Any values outside established reference ranges should be flagged and reviewed.\", },{\"relevance_level\":\"0.35\"}]}\n",
      "Time after finding document excerpts: 1759508555.5293832 (Elapsed: 461.16s)\n",
      "Time after synthesizing sources: 1759508572.3640132 (Elapsed: 477.99s)\n",
      "Time after making llm pretty: 1759508584.2427006 (Elapsed: 489.87s)\n",
      "Evaluating answer quality...\n",
      "Time after evaluating answer quality: 1759508589.015661 (Elapsed: 494.65s)\n",
      "Answer quality satisfactory, proceeding to format the answer.\n",
      "1) Q:  \n",
      "What laboratory tests, specimens, reference limits, and interpretive cut-offs are recommended for detecting and following cases of lead, arsenic, mercury, and cadmium poisoning?\n",
      "\n",
      "2) A:  \n",
      "‚Ä¢ Lead  \n",
      "  ‚Äì Test: Blood Lead Level (BLL) by ICP-MS or GFAAS  \n",
      "  ‚Äì Specimen: 1 mL venous whole blood in a trace-element-free EDTA (royal-blue-top) tube; stable 24 h at room temp or 7 d refrigerated  \n",
      "  ‚Äì Interpretation:  \n",
      "     < 5 ¬µg/dL = normal  \n",
      "     5-19 ¬µg/dL = elevated  \n",
      "     20-44 ¬µg/dL = clinical concern  \n",
      "     45-69 ¬µg/dL = high; consider chelation  \n",
      "     ‚â• 70 ¬µg/dL = critical; urgent action needed  \n",
      "\n",
      "‚Ä¢ Arsenic  \n",
      "  ‚Äì Test: Total arsenic in 24-h urine (ICP-MS or GFAAS) with automatic reflex to inorganic speciation by HPLC-ICP-MS if the total exceeds the lab threshold  \n",
      "  ‚Äì Specimen: Complete 24-h urine, kept cold during collection; stable ‚â§ 1 year at ‚Äì20 ¬∞C  \n",
      "  ‚Äì Interpretation: Any result above the lab trigger prompts speciation to distinguish toxic inorganic forms from benign seafood-derived organo-arsenicals  \n",
      "\n",
      "‚Ä¢ Mercury  \n",
      "  ‚Äì Test: Mercury in 24-h urine by AAS or ICP-MS  \n",
      "  ‚Äì Specimen: 24-h urine (preservative per lab protocol); mix well and record total volume  \n",
      "  ‚Äì Interpretation: 0.0-10.0 ¬µg/L = reference range; ‚â• 20 ¬µg/L = critical value requiring immediate provider notification  \n",
      "\n",
      "‚Ä¢ Cadmium  \n",
      "  ‚Äì Test: Cadmium in random urine by ICP-MS, reported as ¬µg/g creatinine  \n",
      "  ‚Äì Specimen: ‚â• 10 mL random urine in a clean, metal-free container; stable 72 h at 2-8 ¬∞C or long-term at ‚Äì20 ¬∞C  \n",
      "  ‚Äì Interpretation: < 2 ¬µg/g creatinine = normal; ‚â§ 5 ¬µg/g creatinine = upper occupational limit; > 5 ¬µg/g requires repeat analysis and supervisory review  \n",
      "\n",
      "3) Why:  \n",
      "These assays use specimen types (blood or urine) that best reflect the body burden of each metal and employ sensitive, interference-free techniques (ICP-MS, GFAAS, AAS). The stated reference and critical limits are drawn from public-health and occupational guidelines so clinicians can decide when to repeat testing, remove exposure, or start chelation therapy.\n",
      "\n",
      "4) Refs:  \n",
      "‚Ä¢ LEAD_VENOUS_WITH_DEMOGRAPHICS_BLOOD_es1 ‚Äì ‚ÄúNormal: <5 ¬µg/dL ‚Ä¶ Critical: ‚â•70 ¬µg/dL ‚Ä¶ Venous blood in trace-element-free (royal-blue-top) tube; stability room temp ‚â§24 h, 2-8 ¬∞C ‚â§7 d.‚Äù  \n",
      "‚Ä¢ ARSENIC_WITH_REFLEX_24_HOUR_URINE_es1 ‚Äì ‚ÄúSpecimen: 24-hour urine ‚Ä¶ stable frozen at ‚Äì20 ¬∞C up to 1 year ‚Ä¶ If total arsenic exceeds threshold, reflex speciation by HPLC-ICP-MS.‚Äù  \n",
      "‚Ä¢ MERCURY_24_HOUR_URINE_es1 ‚Äì ‚ÄúReference Interval: 0.0-10.0 ¬µg/L; Critical Value: ‚â•20.0 ¬µg/L ‚Ä¶ collected over 24 h.‚Äù  \n",
      "‚Ä¢ CADMIUM_OCCUPATIONAL_EXPOSURE_RANDOM_URINE_es1 ‚Äì ‚ÄúRandom urine sample ‚Ä¶ Normal <2 ¬µg/g creatinine ‚Ä¶ >5 ¬µg/g creatinine, reanalyze and escalate.‚Äù\n",
      "================================================================================\n",
      "\n",
      "üîç QUESTION 9/13:\n",
      "Q: Which liver tests are in the CMP?\n",
      "------------------------------------------------------------\n",
      "Starting time: 1759508589.016093\n",
      "Enhanced question: Which liver-function analytes are included in the Comprehensive Metabolic Panel (CMP)? LIKELY SOP: Comprehensive Metabolic Panel\n",
      "Time after enhancing question: 1759508591.1245482 (Elapsed: 2.11s)\n",
      "Time after identifying relevant documents: 1759508616.8016818 (Elapsed: 27.79s)\n",
      "Time after finding document excerpts: 1759508642.2717314 (Elapsed: 53.26s)\n",
      "Time after synthesizing sources: 1759508659.558283 (Elapsed: 70.54s)\n",
      "Time after making llm pretty: 1759508667.260669 (Elapsed: 78.24s)\n",
      "Evaluating answer quality...\n",
      "Time after evaluating answer quality: 1759508669.6164613 (Elapsed: 80.60s)\n",
      "Answer quality satisfactory, proceeding to format the answer.\n",
      "1) Q: Which liver-function tests are part of the Comprehensive Metabolic Panel (CMP)?\n",
      "\n",
      "2) A: Albumin; Total Protein; Alkaline Phosphatase (ALP); Alanine Aminotransferase (ALT); Aspartate Aminotransferase (AST); Total Bilirubin.\n",
      "\n",
      "3) Why: These six analytes appear in every CMP procedure sheet reviewed and together give information on the liver‚Äôs protein-synthesis capacity (Albumin, Total Protein), biliary tract function (ALP, Total Bilirubin) and hepatocellular integrity (ALT, AST).\n",
      "\n",
      "4) Refs:\n",
      "‚Ä¢ ‚ÄúCOMPREHENSIVE_METABOLIC_PANEL_SERUM_es1‚Äù ‚Äì ‚Äú‚Ä¶Tests included in CMP: ‚Ä¶ Albumin ‚Ä¶ Total Protein ‚Ä¶ ALP ‚Ä¶ ALT ‚Ä¶ AST ‚Ä¶ Total Bilirubin.‚Äù  \n",
      "‚Ä¢ ‚ÄúCOMPREHENSIVE_METABOLIC_PANEL_CMP__es1‚Äù ‚Äì ‚ÄúThe analyzer will perform ‚Ä¶ Albumin ‚Ä¶ Total Protein ‚Ä¶ Bilirubin (Total) ‚Ä¶ ALP ‚Ä¶ AST ‚Ä¶ ALT.‚Äù  \n",
      "‚Ä¢ ‚ÄúCOMPREHENSIVE_METABOLIC_PANEL_PLUS_GLUCOSE_CMP_PLUS_GLUCOSE__es1‚Äù ‚Äì ‚Äú‚Ä¶tests for ‚Ä¶ Albumin ‚Ä¶ Total Protein ‚Ä¶ ALP ‚Ä¶ ALT ‚Ä¶ AST ‚Ä¶ Total Bilirubin‚Ä¶‚Äù\n",
      "================================================================================\n",
      "\n",
      "üîç QUESTION 10/13:\n",
      "Q: What tests can I run on urine?\n",
      "------------------------------------------------------------\n",
      "Starting time: 1759508669.6172116\n",
      "Enhanced question: What laboratory tests are available that can be performed on urine specimens, including chemistry, microbiology, toxicology, and point-of-care assays? LIKELY SOP: Comprehensive Urinalysis, Urine Drug Screening, Urine hCG (Pregnancy), Urine Culture and Sensitivity\n",
      "Time after enhancing question: 1759508672.8326445 (Elapsed: 3.22s)\n",
      "Time after identifying relevant documents: 1759508835.14077 (Elapsed: 165.52s)\n",
      "Time after finding document excerpts: 1759509238.2338414 (Elapsed: 568.62s)\n",
      "Time after synthesizing sources: 1759509272.8929377 (Elapsed: 603.28s)\n",
      "Time after making llm pretty: 1759509285.4537425 (Elapsed: 615.84s)\n",
      "Evaluating answer quality...\n",
      "Time after evaluating answer quality: 1759509290.0098057 (Elapsed: 620.39s)\n",
      "Answer quality satisfactory, proceeding to format the answer.\n",
      "Q: What urine-based laboratory tests can we perform in the areas of chemistry, microbiology, toxicology and point-of-care (POC) testing?  \n",
      "\n",
      "A:  \n",
      "1. General urinalysis  \n",
      "   ‚Ä¢ Comprehensive UA (dip-stick + microscopy with reflex culture if indicated)  \n",
      "   ‚Ä¢ Dip-stick only (Multistix)  \n",
      "   ‚Ä¢ Microscopy only  \n",
      "   ‚Ä¢ Specific-gravity only  \n",
      "\n",
      "2. Chemistry assays (random or timed urines) ‚Äì examples  \n",
      "   ‚Ä¢ Urea, total protein (24 h), protein/creatinine or albumin/creatinine ratios  \n",
      "   ‚Ä¢ Electrolytes & minerals: Ca, Mg, K, Cl, PO‚ÇÑ, osmolality, specific gravity  \n",
      "   ‚Ä¢ Trace/other: Cu/Cr, Ni/Cr, Cd/Cr, methylmalonic acid, quantitative amino acids  \n",
      "\n",
      "3. Toxicology / drug testing  \n",
      "   ‚Ä¢ Broad immunoassay drug screen (multi-class)  \n",
      "   ‚Ä¢ Hybrid controlled-substance panel (20 classes, HRMS + immunoassay)  \n",
      "   ‚Ä¢ Targeted screens: buprenorphine, methadone, cannabinoids  \n",
      "   ‚Ä¢ Prescription / OTC screen (chain-of-custody option)  \n",
      "\n",
      "4. Microbiology  \n",
      "   ‚Ä¢ Routine aerobic urine culture with ID & susceptibility  \n",
      "   ‚Ä¢ Reflex culture from UA if positive  \n",
      "   ‚Ä¢ Rapid urinary antigens: Legionella pneumophila serogroup 1, Streptococcus pneumoniae  \n",
      "   ‚Ä¢ Fungal / parasite work-ups: Candida (yeast) culture, Schistosoma egg exam  \n",
      "\n",
      "5. Point-of-care qualitative tests  \n",
      "   ‚Ä¢ hCG (urine pregnancy test)  \n",
      "\n",
      "Why: The listed tests cover the full spectrum our lab is currently validated to perform on urine specimens, ensuring we can address routine screening (UA, pregnancy), diagnostic microbiology, quantitative chemistries for metabolic evaluation, and comprehensive or targeted drug monitoring.\n",
      "\n",
      "Refs (selected SOPs / excerpts)  \n",
      "‚Ä¢ UA_REFLEX_CULTURE_URINE_MACROSCOPIC_WITH_REFLEX_MICROSCOPIC_AND_CULTURE_IF_INDICATED: ‚ÄúMacroscopic analysis‚Ä¶ chemical reagent-strip testing‚Ä¶ reflex microscopic exam‚Ä¶ reflex urine culture‚Ä¶‚Äù  \n",
      "‚Ä¢ UA_MACROSCOPIC_ONLY: ‚ÄúTesting with Siemens Multistix‚Ä¶ Glucose, Ketone, SG, Blood, pH, Protein, Nitrite, Leukocyte esterase, Urobilinogen.‚Äù  \n",
      "‚Ä¢ DRUG_IMMUNOASSAY_PANEL_URINE: ‚ÄúMethod for the analysis of drug immunoassay panel in urine specimens.‚Äù  \n",
      "‚Ä¢ CONTROLLED_SUBSTANCE_MONITORING_HYBRID_DRUG_PROFILE‚Ä¶: ‚Äú20 drug classes, high-resolution MS and immunoassay screen, random urine.‚Äù  \n",
      "‚Ä¢ BUPRENORPHINE_SCREEN_RANDOM_URINE / METHADONE_URINE / CANNABINOIDS_SCREEN_URINE: individual targeted drug screens.  \n",
      "‚Ä¢ AEROBIC_CULTURE_‚Ä¶_URINE: ‚ÄúInoculate urine samples‚Ä¶ perform colony count, organism ID and susceptibility.‚Äù  \n",
      "‚Ä¢ LEGIONELLA_ANTIGEN_URINE / STREPTOCOCCUS_PNEUMONIAE_ANTIGEN_RANDOM_URINE: rapid antigen detection tests.  \n",
      "‚Ä¢ CHORIONIC_GONADOTROPIN_HCG_QUALITATIVE_URINE: qualitative urine pregnancy testing.  \n",
      "‚Ä¢ UREA_RANDOM_URINE and related chemistries: procedures for quantitative analytes (urea, protein, electrolytes, trace metals, etc.).\n",
      "\n",
      "(Full document titles/excerpts available upon request.)\n",
      "================================================================================\n",
      "\n",
      "üîç QUESTION 11/13:\n",
      "Q: What tests are done on lavender tubes?\n",
      "------------------------------------------------------------\n",
      "Starting time: 1759509290.0104885\n",
      "Enhanced question: Which laboratory assays and panels are performed on specimens collected in lavender-top (EDTA) tubes? LIKELY SOP: Complete Blood Count (CBC), Hemoglobin A1C, Erythrocyte Sedimentation Rate (ESR)\n",
      "Time after enhancing question: 1759509292.881037 (Elapsed: 2.87s)\n",
      "Time after identifying relevant documents: 1759509394.5076299 (Elapsed: 104.50s)\n",
      "JSON parsing error in find_document_excerpts: Expecting property name enclosed in double quotes: line 1 column 384 (char 383)\n",
      "Response:  {\"function\":\"find_document_excerpts\",\"primary_question\":\"Which laboratory assays and panels are performed on specimens collected in lavender-top (EDTA) tubes? LIKELY SOP: Complete Blood Count (CBC), Hemoglobin A1C, Erythrocyte Sedimentation Rate (ESR)\",\"results\":[{\"question\":\"Which laboratory assays and panels are performed on specimens collected in lavender-top (EDTA) tubes?\",  },{\"answer\":\"Within this SOP, EDTA (lavender-top) specimens are used for hematologic molecular tests‚Äîi.e., nucleic-acid‚Äìbased assays such as real-time PCR and next-generation sequencing for detecting genetic mutations or gene-expression changes. The document does not list routine assays such as CBC, Hemoglobin A1c, or ESR.\",  },{\"document\":\"HEMATOLOGIC_MOLECULAR_ALGORITHM_es1\",  },{\"excerpt\":\"SPECIMEN REQUIREMENTS ‚Ä¢ Acceptable specimens: EDTA anticoagulated blood, bone marrow aspirates or biopsies.‚Ä¶ Hematologic molecular tests refer to diagnostic tests that analyze nucleic acids, such as DNA and RNA, to detect genetic mutations, chromosomal abnormalities, or changes in gene expression associated with hematologic disorders.\",  },{\"relevance_level\":\"0.9\"}]}\n",
      "Time after finding document excerpts: 1759509634.9516084 (Elapsed: 344.94s)\n",
      "Time after synthesizing sources: 1759509647.731776 (Elapsed: 357.72s)\n",
      "Time after making llm pretty: 1759509654.4104018 (Elapsed: 364.40s)\n",
      "Evaluating answer quality...\n",
      "Time after evaluating answer quality: 1759509656.3127613 (Elapsed: 366.30s)\n",
      "Answer quality satisfactory, proceeding to format the answer.\n",
      "Q: Which laboratory tests are typically run on blood drawn into lavender-top (EDTA) tubes?  \n",
      "\n",
      "A:  \n",
      "‚Ä¢ Complete Blood Count (CBC) panel (WBC, RBC, Hb, Hct, MCV, MCH, MCHC, RDW, platelet count)  \n",
      "‚Ä¢ Hemoglobin A1c (HbA1c)  \n",
      "‚Ä¢ Erythrocyte Sedimentation Rate (ESR)  \n",
      "\n",
      "Why: Lavender-top tubes contain EDTA, an anticoagulant that prevents clotting and preserves cellular elements, making them the standard choice for routine hematology tests (CBC, ESR) and glycated hemoglobin measurement (HbA1c).  \n",
      "\n",
      "Refs:  \n",
      "1. COMPLETE_BLOOD_COUNT_PERCUTANEOUS_UMBILICAL_CORD_BLOOD_SAMPLING_PUBS_es1 ‚Äì ‚ÄúK2EDTA tubes‚Ä¶ Complete Blood Count (CBC): WBC, RBC, Hb, Hct, MCV, MCH, MCHC, RDW, platelet count.‚Äù  \n",
      "2. HEMOGLOBIN_A1C_BLOOD_es1 ‚Äì ‚ÄúAcceptable Specimens: Whole blood collected in EDTA (lavender-top) tubes.‚Äù  \n",
      "3. SEDIMENTATION_RATE_ESR_BLOOD_es1 ‚Äì ‚ÄúContainer: Ethylenediaminetetraacetic Acid (EDTA) tube (Lavender top).‚Äù\n",
      "================================================================================\n",
      "\n",
      "üîç QUESTION 12/13:\n",
      "Q: What tests are done on royal blue tubes?\n",
      "------------------------------------------------------------\n",
      "Starting time: 1759509656.3131502\n",
      "Enhanced question: Which laboratory tests are performed using royal blue top trace-element collection tubes (e.g., lead, zinc, copper, mercury, other heavy metal or trace element assays)? LIKELY SOP: Trace Element / Heavy Metal Testing\n",
      "Time after enhancing question: 1759509659.5100071 (Elapsed: 3.20s)\n",
      "LLM invoke error in _identify_relevant_documents_batch: ('Connection aborted.', RemoteDisconnected('Remote end closed connection without response'))\n",
      "Time after identifying relevant documents: 1759509758.2916632 (Elapsed: 101.98s)\n",
      "Time after finding document excerpts: 1759509828.9452293 (Elapsed: 172.63s)\n",
      "Time after synthesizing sources: 1759509850.171351 (Elapsed: 193.86s)\n",
      "Time after making llm pretty: 1759509859.4014206 (Elapsed: 203.09s)\n",
      "Evaluating answer quality...\n",
      "Time after evaluating answer quality: 1759509863.2121344 (Elapsed: 206.90s)\n",
      "Answer quality satisfactory, proceeding to format the answer.\n",
      "1) Q: Which laboratory tests require collection in a royal-blue, trace-element tube?  \n",
      "\n",
      "2) A: Any test that measures trace metals or heavy metals in blood or serum ‚Äî for example:  \n",
      "   ‚Ä¢ Lead (whole blood)  \n",
      "   ‚Ä¢ Zinc (serum)  \n",
      "   ‚Ä¢ Cadmium (whole blood)  \n",
      "   ‚Ä¢ Selenium (whole blood or serum)  \n",
      "   ‚Ä¢ Chromium (serum)  \n",
      "   ‚Ä¢ Bismuth (whole blood)  \n",
      "   ‚Ä¢ Bromine (whole blood)  \n",
      "   ‚Ä¢ Titanium (serum)  \n",
      "   ‚Ä¢ Mercury (whole blood)  \n",
      "   ‚Ä¢ Platinum (serum)  \n",
      "   ‚Ä¢ Aluminum (serum)  \n",
      "   ‚Ä¢ Manganese (whole blood)  \n",
      "\n",
      "3) Why: Royal-blue tubes are manufactured without trace-metal contaminants and are available either with EDTA (for whole-blood assays) or without additives (for serum). Using them prevents external metal contamination and ensures accurate quantification of very low-level elements.  \n",
      "\n",
      "4) Refs (selected excerpts):  \n",
      "   ‚Ä¢ LEAD_VENOUS_WITH_DEMOGRAPHICS_BLOOD_es1 ‚Äì ‚ÄúCollection tube: Trace element-free (royal blue top with EDTA).‚Äù  \n",
      "   ‚Ä¢ ZINC_SERUM_es1 ‚Äì ‚ÄúSerum collected in a trace element-free, royal blue-top tube (no additive).‚Äù  \n",
      "   ‚Ä¢ CADMIUM_BLOOD_es1 ‚Äì ‚ÄúWhole blood collected in royal blue-top tubes containing EDTA.‚Äù  \n",
      "   ‚Ä¢ SELENIUM_BLOOD_es1 / SELENIUM_SERUM_es1 ‚Äì ‚ÄúRoyal blue-top (K2 EDTA) tube‚Äù / ‚ÄúRoyal blue-top (trace element) tube containing no anticoagulant.‚Äù  \n",
      "   ‚Ä¢ CHROMIUM_SERUM_es1 ‚Äì ‚ÄúSerum collected in a royal blue top (trace element) tube.‚Äù  \n",
      "   ‚Ä¢ BISMUTH_BLOOD_es1 ‚Äì ‚ÄúWhole blood collected in a royal blue-top (EDTA) tube.‚Äù  \n",
      "   ‚Ä¢ BROMINE_-_TOTAL_BLOOD_es1 ‚Äì ‚ÄúWhole blood collected in a trace element-free container such as a royal blue-top (EDTA) tube.‚Äù  \n",
      "   ‚Ä¢ TITANIUM_SERUM_es1 ‚Äì ‚ÄúSerum collected in a trace element-free (royal blue-top) tube.‚Äù  \n",
      "   ‚Ä¢ MERCURY_BLOOD_es1 ‚Äì ‚ÄúBlood specimens collected in trace element-free‚Ä¶ dark blue top with EDTA.‚Äù  \n",
      "   ‚Ä¢ PLATINUM_SERUM_es1 ‚Äì ‚ÄúSerum collected in a trace-element free, clot activator tube (royal blue-top).‚Äù  \n",
      "   ‚Ä¢ ALUMINUM_SERUM_es1 ‚Äì ‚ÄúTransfer serum to trace metal-free collection tubes (e.g., BD Vacutainer Trace Element Serum Tubes).‚Äù  \n",
      "   ‚Ä¢ MANGANESE_BLOOD_es1 ‚Äì ‚ÄúWhole blood collected in trace metal-free tubes.‚Äù\n",
      "================================================================================\n",
      "\n",
      "üîç QUESTION 13/13:\n",
      "Q: Which tests can be messed up by hemoglobin variants?\n",
      "------------------------------------------------------------\n",
      "Starting time: 1759509863.2128134\n",
      "Enhanced question: Which laboratory tests are susceptible to interference or inaccurate results because of hemoglobin variants (e.g., HbS, HbC, HbE)? LIKELY SOP: Hemoglobin A1c\n",
      "Time after enhancing question: 1759509866.493199 (Elapsed: 3.28s)\n",
      "Time after identifying relevant documents: 1759509903.7257664 (Elapsed: 40.51s)\n",
      "Time after finding document excerpts: 1759509906.8764918 (Elapsed: 43.66s)\n",
      "Time after synthesizing sources: 1759509906.8766024 (Elapsed: 43.66s)\n",
      "Time after making llm pretty: 1759509909.8247283 (Elapsed: 46.61s)\n",
      "Evaluating answer quality...\n",
      "Time after evaluating answer quality: 1759509912.3251867 (Elapsed: 49.11s)\n",
      "Answer quality satisfactory, proceeding to format the answer.\n",
      "1) Q: Which laboratory tests can give inaccurate results when hemoglobin variants such as HbS, HbC, or HbE are present?\n",
      "\n",
      "2) A: Hemoglobin A1c.\n",
      "\n",
      "3) Why: Certain Hemoglobin A1c assay methods react differently to atypical hemoglobin molecules, so the presence of HbS, HbC, HbE, and other variants can distort the reported A1c value.\n",
      "\n",
      "4) Refs:  \n",
      "‚Ä¢ HEMOGLOBIN_A1C_BLOOD_es1 ‚Äì ‚ÄúMETHOD LIMITATIONS: Hemoglobin variants can interfere with some methods. Verify if the method used is influenced by common hemoglobin variants.‚Äù\n",
      "================================================================================\n"
     ]
    }
   ],
   "source": [
    "# Comprehensive SOP Query Test - Sample Questions\n",
    "sample_questions = [\n",
    "    \"How do you make sure the CD30 stain worked right?\",\n",
    "    \"What problem could ruin both immunostain and blood tests? How to fix?\",\n",
    "    \"I'm worried there is a typo in an SOP; I need to compare the reference ranges for PT.\",\n",
    "    \"I just received an add-on request for an A1c, and I see a BMP in my lab from Sunday.\",\n",
    "    \"What tests can I run on FFPE tissue?\",\n",
    "    \"What tests need patient consent?\",\n",
    "    \"What genetic tests are available?\",\n",
    "    \"I am concerned about metal poisoning.\",\n",
    "    \"Which liver tests are in the CMP?\",\n",
    "    \"What tests can I run on urine?\",\n",
    "    \"What tests are done on lavender tubes?\",\n",
    "    \"What tests are done on royal blue tubes?\",\n",
    "    \"Which tests can be messed up by hemoglobin variants?\"\n",
    "]\n",
    "\n",
    "print(f\"Testing {len(sample_questions)} sample questions...\")\n",
    "print(\"=\" * 80)\n",
    "\n",
    "for i, question in enumerate(sample_questions, 1):\n",
    "    print(f\"\\nüîç QUESTION {i}/{len(sample_questions)}:\")\n",
    "    print(f\"Q: {question}\")\n",
    "    print(\"-\" * 60)\n",
    "    \n",
    "    try:\n",
    "        sop_query = SOPQuery(debug=0)\n",
    "        res, history = sop_query.ask_sop(question, sops)  # Fixed: added sops parameter\n",
    "        print(f\"{res}\")\n",
    "    except Exception as e:\n",
    "        print(f\"‚ùå ERROR: {e}\")\n",
    "    \n",
    "    print(\"=\" * 80)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "jupyter-env",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.2"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
